Dr Mattéa Finelli is an Assistant Professor at the University of Nottingham. The Finelli group (mattea-finelli-lab.com) studies the molecular mechanisms of neurodegenerative diseases including amyotrophic lateral sclerosis and Alzheimer's disease. It focuses on how changes in structure, interaction, and activity of proteins of the brain can impact cellular function in health and in neurological conditions. To address these questions, the Finelli group uses a combination of cellular models (cell lines, primary, stem cell-derived models), gene editing, functional and recombinant protein-based assays, as well as in silico approaches (drug screening, protein modelisation).

Mattéa received a MSc in bioengineering from SupAgro (France), and a MRes in Biomedical Research from Imperial College London, before being awarded her DPhil from the University of Oxford. She completed her postdoctoral work at Mount Sinai School of Medicine (New York), and the University of Nottingham, and started her independent research at the University of Nottingham in 2020 with an Anne McLaren Fellowship.